Novogene Co., Ltd. (SHA:688315)

Novogene Revenue

Novogene had revenue of 557.40M CNY in the quarter ending June 30, 2026, with 3.59% growth. This brings the company's total for the last twelve months to 2.28B, up 5.97% year-over-year. In the year 2025, Novogene had annual revenue of 2.21B with 4.66% growth. That makes Novogene the 13,586th largest company in the world by revenue and 2,390th in China.

• Revenue (ttm): 2.28B
• Revenue Growth: +5.97%
• P/S Ratio: 3.23
• Revenue / Employee: 1.03M
• Employees: 2,227
• Market Cap: 7.84B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Sequencing Platform Services 1.06B 48.2%
• Life Science Basic Research Service 791.82M 36.0%
• Medical Research and Technical Services 289.20M 13.1%
• Others 58.99M 2.7%

By Geography

Chart

• Mainland China 1.11B 50.5%
• Hong Kong, Macao, Taiwan and Overseas 1.09B 49.5%

Fiscal year ended Dec 31, 2025 See the full Novogene breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.21B	98.32M	4.66%
Dec 31, 2024	2.11B	109.21M	5.45%
Dec 31, 2023	2.00B	76.47M	3.97%
Dec 31, 2022	1.93B	59.24M	3.17%
Dec 31, 2021	1.87B	376.37M	25.26%

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error